Abhimanyu Roy, Executive Director at Avalon Consulting, shared his views in the article “Budget 2026: Healthcare leaders call ‘Biopharma Shakti’ and regional hub initiatives transformative”, published in Pharmabiz.
He highlighted that the Budget’s flagship ‘Biopharma Shakti’ programme, with its focused push on biopharma innovation and ecosystem development, can be a game-changer in positioning India as a global hub for advanced therapies and high-value manufacturing. He also noted that initiatives to build regional medical and tourism hubs, alongside support for electronics and semiconductor manufacturing, will strengthen healthcare delivery and accelerate localisation in critical segments such as medical devices.
Read here – https://www.pharmabiz.com
